Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention

Aims: Cardiovascular risk persists despite intensive lipid lowering therapy using statins. Serum levels of lipoprotein (a) [Lp(a)] can be a residual cardiovascular risk for adverse events. Aim of the present study was to evaluate the impact of Lp(a) on long-term clinical outcomes in patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Suwa, Satoru, Ogita, Manabu, Miyauchi, Katsumi, Sonoda, Taketo, Konishi, Hirokazu, Tsuboi, Shuta, Wada, Hideki, Naito, Ryo, Dohi, Tomotaka, Kasai, Takatoshi, Okazaki, Shinya, Isoda, Kikuo, Daida, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684478/
https://www.ncbi.nlm.nih.gov/pubmed/28321012
http://dx.doi.org/10.5551/jat.38794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684478/
https://www.ncbi.nlm.nih.gov/pubmed/28321012
http://dx.doi.org/10.5551/jat.38794

Ejemplares similares